A bio-repository that stores biological samples for research is referred to as a biobank. These bio-repositories play an integral role in the research and development activities associated with drug discovery and development. Biobanks also provide inevitable assistance in gaining prospective on orphan diseases especially the ones associated with single-nucleotide polymorphisms, via genome wide association studies.
Research results suggest that approximately 90% of proposed drugs fail to exhibit efficacy levels during clinical trials. In an attempt to avoid the high costs associated with such drug failures, researchers are rapidly adhering to human tissue samples and stem cell models to execute pre-clinical trials. Increasing demand for tissue samples and stem cell models will serve as a significant driver for the global biobanks market. Moreover, rising adoption of stem cell treatments and implementation of initiatives aimed at the standardization of biobanking procedures will drive the growth of this market.
The future of this market will be fuelled majorly by factors such as the automation of storage processes via RFID (radiofrequency identification) and MEMS (micro electromechanical systems) technologies and the introduction of new products such as the development of reagents by Biomatrica and IntegenX. These reagents are used to enable the storage of DNAs and RNAs at room temperature by stabilizing them.
The disease biobanks market dominates the overall biobanks market in terms of share. The presence of a wide application base for disease based biobanks in the field of drug discovery and development attributes to its high market share. However, the population based biobanks market is expected to grow at a relatively higher growth rate during the forecast period on account of rising patient awareness levels pertaining to stem cell treatments and bio-preservation.
North America and Europe collectively hold the largest share of the biobanks market. Rising number of drug discovery and development related research and development initiatives and the presence of sophisticated biobank facilities enabled with recent technological advancements, account for the aforementioned fact.
This research study encompasses a competitive landscape of the biobanks market. Revenue analysis, product benchmarking and strategic developments of key market players such as Abbott Laboratories Inc., Bristol-Myers Squibb Co., Johnson and Johnson Ltd., Roche Ltd., Teva Pharmaceuticals, Affymetrix Inc and others are also provided in this report.
Grand View Research offers special pricing for:
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.